SNG.L
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Industry
Biotechnology
IPO Date
2004-10-26
Stock Exchange
LSE
Ticker
SNG.L
According to Synairgen plc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.06M. This represents a change of 106.06% compared to the average of 515.35K of the last 4 quarters.
The mean historical Enterprise Value of Synairgen plc over the last ten years is 42.02M. The current 1.06M Enterprise Value has changed 152.73% with respect to the historical average. Over the past ten years (40 quarters), SNG.L's Enterprise Value was at its highest in in the December 2005 quarter at 2.62B. The Enterprise Value was at its lowest in in the December 2023 quarter at -1835315.20.
Average
42.02M
Median
9.13M
Minimum
-1836737.50
Maximum
267.00M
Discovering the peaks and valleys of Synairgen plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.39%
Maximum Annual Enterprise Value = 267.00M
Minimum Annual Increase = -149.82%
Minimum Annual Enterprise Value = -1836737.50
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | -1836737.50 | -149.82% |
| 2022 | 3.69M | -98.62% |
| 2021 | 267.00M | 204.94% |
| 2020 | 87.56M | 3.39% |
| 2019 | 2.51M | -72.26% |
| 2018 | 9.04M | 16.49% |
| 2017 | 7.76M | -15.82% |
| 2016 | 9.22M | -37.40% |
| 2015 | 14.73M | -28.16% |
| 2014 | 20.51M | -28.62% |
The current Enterprise Value of Synairgen plc (SNG.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
89.62M
5-year avg
71.78M
10-year avg
42.02M
Synairgen plc’s Enterprise Value is less than NetScientific plc (16.55M), less than BiVictriX Therapeutics Plc (5.24M), less than Advanced Oncotherapy plc (58.59M), less than MGC Pharmaceuticals Limited (27.93M), greater than Destiny Pharma plc (-3509485.00), less than Celadon Pharmaceuticals Plc (12.68M), less than Theracryf Plc (2.40M), less than Yourgene Health Plc (27.05M), greater than ReNeuron Group plc (-5684826.72), less than Induction Healthcare Group PLC (5.52M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 16.55M | N/A | |
| 5.24M | N/A | |
| 58.59M | N/A | |
| 27.93M | N/A | |
| -3509485.00 | N/A | |
| 12.68M | N/A | |
| 2.40M | N/A | |
| 27.05M | N/A | |
| -5684826.72 | N/A | |
| 5.52M | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synairgen plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synairgen plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Synairgen plc's Enterprise Value?
What is the highest Enterprise Value for Synairgen plc (SNG.L)?
What is the 3-year average Enterprise Value for Synairgen plc (SNG.L)?
What is the 5-year average Enterprise Value for Synairgen plc (SNG.L)?
How does the current Enterprise Value for Synairgen plc (SNG.L) compare to its historical average?